Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

BioCryst Pharmaceuticals Inc. (BCRX)

NASDAQ

$8.32

$+0.15

(+1.84%)

Pre-Market

BioCryst Pharmaceuticals Inc. (BCRX) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

BioCryst Pharmaceuticals Inc. (BCRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $8.32, with a market capitalisation of $2.10B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.00 to $11.22. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.10B
Open	$8.16
Day's High	$23.00
Day's Low	$0.85
Previous Close	$8.16
Volume	200.00
Average Volume	4.51M
P/E Ratio	--
52-Week High	$11.22
52-Week Low	$6.00
Dividend Yield	--
Earnings Date	--

BioCryst Pharmaceuticals Inc. (BCRX) Pre-Market Stock Price

BioCryst Pharmaceuticals Inc. (BCRX) is trading at $8.32 in pre-market trading as of 2026-09-16 08:02:00, up 1.90% ($0.15) from the previous close of $8.16

Pre-market trading shows how investors are pricing BCRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

BioCryst Pharmaceuticals Inc. (BCRX) 7-Day Stock Price Change

Over the past seven days, BioCryst Pharmaceuticals Inc. (BCRX) moved from $9.96 to $8.32, representing a decline of 16.52% ($1.65).

The stock traded between $8.02 and $10.10 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 5.73 million shares, up versus the previous seven-day period, indicating higher trading activity.

BCRX 52-Week Price Position

Position in Range: 44.3%

52W Low$6.00

52W High$11.22

BCRX is currently trading at $8.32, placing it 44.3% of the way from its 52-week low of $6.00 to its 52-week high of $11.22. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BioCryst Pharmaceuticals Inc. (BCRX)?

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

BioCryst Pharmaceuticals Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	435
Exchange	NASDAQ
Company Website	https://www.biocryst.com

How to Buy BioCryst Pharmaceuticals Inc. (BCRX) Stock on MEXC

Eligible investors can buy real shares of BioCryst Pharmaceuticals Inc. (BCRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BCRX and Place Your Order

Open the RealStocks trading page and search for BCRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BioCryst Pharmaceuticals Inc. (BCRX) stock price today?

BioCryst Pharmaceuticals Inc. (BCRX) is currently trading at $ 8.32, up 1.90% ($0.15) from the previous close of $ 8.16. Intraday prices update in real time during regular trading hours.

2.Is BCRX stock going up or down today?

As of 2026-09-16 08:02:00, BCRX is trading at $ 8.32, up 1.90% ($0.15) from its previous close of $ 8.16. The stock has traded between $ 0.85 and $ 23.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is BCRX pre-market price?

As of 2026-09-16 08:02:00, BCRX is trading at $ 8.32 in pre-market trading, up 1.90% ($0.15) from the previous close of $ 8.16. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BCRX after-hours price?

As of 2026-09-16 08:02:00, BCRX is trading at $ 8.14 in after-hours trading, down 0.31% ($0.03) from the regular-session close of $ 8.16. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BCRX stock trading now?

BCRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BCRX sit relative to its 52-week high and low?

Over the past 52 weeks, BCRX has traded between a low of $ 6.00 and a high of $ 11.22. At $ 8.32, the stock is positioned 44.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BioCryst Pharmaceuticals Inc. in?

BioCryst Pharmaceuticals Inc. (BCRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BioCryst Pharmaceuticals Inc.'s market capitalisation and where is it listed?

BioCryst Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.10B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BCRX valued in terms of P/E ratio and EPS?

BCRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.51. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BioCryst Pharmaceuticals Inc. pay a dividend?

BioCryst Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.